Evidence map›Paper›PMID 35874724›Full record

ArticleFrontiers in immunology2022

IL-18/IL-18R Signaling Is Dispensable for ILC Development But Constrains the Growth of ILCP/ILCs.

Mengying Xie, Mingying Zhang, Mengyuan Dai, Shan Yue, Zhao Li, Ju Qiu, Chenqi Lu, Wei Xu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Mengying XieDepartment of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Mingying ZhangDepartment of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Mengyuan DaiDepartment of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Shan YueDepartment of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Zhao LiChinese Academy of Sciences (CAS) Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.
Ju QiuChinese Academy of Sciences (CAS) Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.
Chenqi LuDepartment of Biostatistics and Computational Biology, State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, China.
Wei XuDepartment of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Fudan University · CNShanghai Institutes for Biological Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Innate lymphoid cells (ILCs) develop from ILC progenitors in the bone marrow. Various ILC precursors (ILCPs) with different ILC subset lineage potentials have been identified based on the expression of cell surface markers and ILC-associated key transcription factor reporter genes. This study characterized an interleukin (IL)-7Rα

Indexed as

Immunity, InnateInterleukin-18Interleukin-18 Receptor alpha SubunitLymphocytesAnimalsCell DifferentiationMiceSingle-Cell AnalysisIl18r1 protein, mouseInterleukin-18Interleukin-18 Receptor alpha SubunitcytokinedevelopmenthomeostasisIL-18/IL-18R signalinginnate lymphoid cell

Identifiers

PMID35874724
PMCPMC9304618
OpenAlexW4284896374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.